AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

TELIX PHARMACEUTICALS LTD

24.840

-1.960-7.31%

Volume:1.98M

Turnover:50.64M

Market Cap:8.39B

PE:171.78

High:26.340

Open:26.110

Low:24.730

Close:26.800

Loading ...

Overview Company News Filings

Codan And 2 Other ASX Stocks That May Be Trading At A Discount

Simply Wall St.

Duratec And 2 Other Stocks On The ASX That May Be Priced Below Fair Value

Simply Wall St.

BUZZ-Australia's Telix Pharmaceuticals hits record high after winning European approval

BRIEF-Telix Pharmaceuticals Says Illuccix Receives European Approval

Why Insignia, Lovisa, Megaport, and Telix shares are charging higher today

Telix Pharmaceuticals Receives Positive Decision on Marketing Application in Europe; Shares Hit All-Time High

MT Newswires Live

Guess which ASX 200 stock is jumping to record high on big European news

Telix Pharmaceuticals Secures Marketing Approval for Illuccix in Europe

MT Newswires Live

ASX Alert-Illuccix Receives European Approval-Tlx.ax

THOMSON REUTERS

How buying undervalued ASX stocks can deliver great returns

BUZZ-Morningstar hikes fair value estimate on Australia's Telix on revenue growth

Your top-tipped ASX growth stocks for 2025

BUZZ-Australia's Telix Pharmaceuticals rises on FY24 revenue forecast beat

Why CAR Group, Peninsula Energy, Star, and Telix shares are charging higher today

Australia's Telix eyes best day in nearly 4 months on revenue growth

Guess which ASX 200 share is up 7% after smashing FY24 guidance

ASX Preview: Australian Shares to Open Higher Despite Mixed Wall Street Session

MT Newswires Live

ASX Market Open: Monday bloodbath to turn into Oz shares, $A uptick | Jan 14, 2024

The Market Herald

Telix Pharmaceuticals' Revenue Surges 46% in Q4; Full-Year Revenue Beats Guidance

MT Newswires Live

Best ASX 200 shares vs. best suburbs for property investment in 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TLX.AU/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","market":"AU","secType":"STK","nameCN":"TELIX PHARMACEUTICALS LTD","latestPrice":24.84,"timestamp":1747021277367,"preClose":26.8,"halted":0,"volume":1984749,"delay":0,"nameEN":"TELIX PHARMACEUTICALS LTD","floatShares":274906865,"shares":337878497,"eps":0.1446,"marketStatus":"Trading","change":-1.96,"latestTime":"05-12 13:41:21 AEST","open":26.11,"high":26.34,"low":24.73,"amount":50638479,"amplitude":0.060075,"askPrice":24.86,"askSize":10871,"bidPrice":24.84,"bidSize":409,"shortable":3,"etf":0,"ttmEps":0.1446,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1747029600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":26.8,"openAndCloseTimeList":[[1747008000000,1747029600000]],"volumeRatio":2.219179,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX.AU\",,,,,undefined,":{"symbol":"TLX.AU","floatShares":274906865,"roa":"5.33%","roe":"13.92%","lyrEps":0.150709,"volumeRatio":2.219179,"shares":337878497,"dividePrice":0,"high":26.34,"amplitude":0.060075,"preClose":26.8,"low":24.73,"week52Low":14.42,"pbRate":"14.77","psRate":"10.72","week52High":31.97,"institutionHeld":0,"latestPrice":24.84,"committee":-0.927482,"eps":0.1446,"divideRate":0,"volume":1984749,"delay":0,"ttmEps":0.1446,"open":26.11,"prevYearClose":24.61,"prevWeekClose":26.8,"prevMonthClose":27.13,"prevQuarterClose":26.52,"fiveDayClose":29.16,"twentyDayClose":24.42,"sixtyDayClose":27.48},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX.AU\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2505210438","title":"Codan And 2 Other ASX Stocks That May Be Trading At A Discount","url":"https://stock-news.laohu8.com/highlight/detail?id=2505210438","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505210438?lang=en_us&edition=fundamental","pubTime":"2025-01-21 16:07","pubTimestamp":1737446857,"startTime":"0","endTime":"0","summary":"As the ASX200 index shows resilience by closing up 0.66% at 8,402 points, investors are keenly observing market movements amid global trade uncertainties linked to Donald Trump's tariff decisions. With sectors like Financials and Materials leading gains, identifying undervalued stocks becomes crucial for those looking to capitalize on potential market inefficiencies. In this context, Codan and two other ASX stocks may present opportunities for investors seeking value in a fluctuating economic landscape.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Codan is trading at A$15.55, significantly below its estimated fair value of A$26.7, suggesting it may be undervalued based on cash flows. The company's earnings are projected to grow at 17.42% annually, outpacing the Australian market's 12.7% forecasted growth rate. Revenue is expected to increase by 10.6% per year, also above market expectations but not exceeding the high-growth benchmark of 20%. Codan's strong return on equit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/codan-2-other-asx-stocks-080737717.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["RDY.AU","BK7144","DTL.AU","BK7067","BK7064","BK7061","ALX.AU","XKO.AU","BK7090","XJO.AU","INA.AU","TLX.AU","VAU.AU","MPL.AU","BK7095","BK7087","MLG.AU","BK7159","BK7084","SYR.AU","CDA.AU","CHC.AU","BK7507","XAO.AU","BK7089","MAD.AU","BK7104","BK7506","GOR.AU","BK7016"],"gpt_icon":0},{"id":"2504478756","title":"Duratec And 2 Other Stocks On The ASX That May Be Priced Below Fair Value","url":"https://stock-news.laohu8.com/highlight/detail?id=2504478756","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504478756?lang=en_us&edition=fundamental","pubTime":"2025-01-20 16:06","pubTimestamp":1737360396,"startTime":"0","endTime":"0","summary":"As the ASX200 closed up 0.45% at 8,347 points, investors are keenly observing how international political shifts might influence market dynamics, with sectors like IT and Real Estate leading gains. In this environment of cautious optimism, identifying stocks that may be priced below their fair value becomes crucial for investors seeking opportunities amidst changing global influences.Top 10 Undervalued Stocks Based On Cash Flows In Australia. Overview: Duratec Limited, with a market cap of A$404.53 million, provides assessment, protection, remediation, and refurbishment services for steel and concrete infrastructure in Australia.Overview: Judo Capital Holdings Limited, with a market cap of A$2.08 billion, provides a range of banking products and services specifically tailored for small and medium businesses in Australia through its subsidiaries.Judo Capital Holdings is trading at A$1.86, slightly below its estimated fair value of A$2.10, suggesting some undervaluation based on cash flo","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/duratec-2-other-stocks-asx-080636283.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["RDY.AU","BK7016","BK7507","DUR.AU","SYR.AU","ALX.AU","MLG.AU","TLX.AU","XJO.AU","BK7064","JDO.AU","MAD.AU","BK7090","BK7144","BK7067","XAO.AU","BK7055","VAU.AU","BK7087","DTL.AU","BK7159","BK7104","BK7061","BK7135","XKO.AU","CHC.AU","BK7095","JDOPA.AU","INA.AU"],"gpt_icon":0},{"id":"2504975461","title":"BUZZ-Australia's Telix Pharmaceuticals hits record high after winning European approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2504975461","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504975461?lang=en_us&edition=fundamental","pubTime":"2025-01-17 09:18","pubTimestamp":1737076680,"startTime":"0","endTime":"0","summary":"** Shares of Telix Pharmaceuticals    rise 2.3% to a record high of A$26.46   ** The biopharma co says its Illuccix, a prostate cancer imaging agent, received European approval   ** Says all 18 European Economic Area member states agreed Illuccix should be approved   ** Co stock on track for a fifth consecutive session of gains, if current trend holds   ** Stock up over 7% YTD including session's moves ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","XJO.AU","XAO.AU","XKO.AU","BK7067"],"gpt_icon":0},{"id":"2504756069","title":"BRIEF-Telix Pharmaceuticals Says Illuccix Receives European Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2504756069","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504756069?lang=en_us&edition=fundamental","pubTime":"2025-01-17 09:15","pubTimestamp":1737076558,"startTime":"0","endTime":"0","summary":"BRIEF-Telix Pharmaceuticals Says Illuccix Receives European ApprovalJan 17 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX:ASX ALERT-ILLUCCIX RECEIVES EUROPEAN APPROVALFurther company coverage: TLX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250117:nFWN3OC11U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","TLX.AU"],"gpt_icon":0},{"id":"2504719109","title":"Why Insignia, Lovisa, Megaport, and Telix shares are charging higher today","url":"https://stock-news.laohu8.com/highlight/detail?id=2504719109","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504719109?lang=en_us&edition=fundamental","pubTime":"2025-01-17 09:01","pubTimestamp":1737075705,"startTime":"0","endTime":"0","summary":"In early afternoon trade, theS&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up slightly to 8,330.3 points. Four ASX shares that are ri","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/17/why-insignia-lovisa-megaport-and-telix-shares-are-charging-higher-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["LU2023251221.USD","LU0795875086.SGD","LU1074936037.SGD","LU2089284900.SGD","LOV.AU","LU1732800096.USD","LU0158827948.USD","LU0006306889.USD","BK7043","LU0795875169.SGD","LU2357305700.SGD","IE00BZ1G4Q59.USD","LU0971096721.USD","BK7503","BK4516","LU0225283273.USD","LU2111349929.HKD","BK7067","BK4534","LU0314104364.USD","LU1668664300.SGD","DCP","LU1720051017.SGD","LU0106831901.USD","LU1989772840.SGD","BK4504","LU0912757837.SGD","BK4585","LU1989772923.USD","LU2347655156.SGD","XJO.AU","TLX.AU","LU0320765646.SGD","MP1.AU","BK4588","LU1720051108.HKD","LU1162221912.USD","BK4127","LU2271345857.HKD","BK7128","LU0098860793.USD","LU0106261372.USD","LU2028103732.USD","MAA","BK4215","LU0158827781.USD","BK7062","IFL.AU","LU0267386448.USD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2504978365","title":"Telix Pharmaceuticals Receives Positive Decision on Marketing Application in Europe; Shares Hit All-Time High","url":"https://stock-news.laohu8.com/highlight/detail?id=2504978365","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504978365?lang=en_us&edition=fundamental","pubTime":"2025-01-17 08:27","pubTimestamp":1737073626,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  received a positive decision on its marketing authorization application in Europe for its imaging product, Illuccix, used in a positron emission tomography scan to detect prostate cancer, according to a Friday filing with the Australian bourse.The German Federal Institute for Drugs and Medical Devices, issued a final assessment report, confirming that Illuccix should receive marketing authorization from the reference member state and all 18 European Economic Area concerned member states, the filing said.The regulatory process will now transition into an administrative national phase for commercial launch in each country, according to the filing.Shares rose 3% in morning trade Friday and earlier hit an all-time high.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX","BK7067","TLX.AU"],"gpt_icon":0},{"id":"2504597844","title":"Guess which ASX 200 stock is jumping to record high on big European news","url":"https://stock-news.laohu8.com/highlight/detail?id=2504597844","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504597844?lang=en_us&edition=fundamental","pubTime":"2025-01-17 07:18","pubTimestamp":1737069517,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals Ltd  shares are ending the week on a positive note. In morning trade on Friday, the ASX 200 healthcare stock is up 4.5% to a record high of $27.00. Why is this ASX 200 healthcare stock racing higher?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/17/guess-which-asx-200-stock-is-jumping-to-record-high-on-big-european-news/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK4213","TGA.AU","LU1894683348.USD","RMS.AU","BK7067","TGA","BK4208","BCR","BK4144","PET.AU","BK4588","MAA","PET","BK4192","BK7104","BK7047","LU1894683264.USD","DCP","BK4215","EEA","BK4585","TLX.AU","LU2346227817.USD","BK7001","LU2637428348.USD","CMS","BK7506"],"gpt_icon":0},{"id":"2504921224","title":"Telix Pharmaceuticals Secures Marketing Approval for Illuccix in Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2504921224","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504921224?lang=en_us&edition=fundamental","pubTime":"2025-01-17 07:03","pubTimestamp":1737068608,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  said Thursday it received a positive decision on its marketing authorization application for Illuccix, its prostate cancer positron emission tomography imaging agent, in Europe.The application was submitted via a decentralized procedure, with the German Federal Institute for Drugs and Medical Devices acting as the reference member state. The RMS and all 18 European Economic Area Concerned Member States have agreed that Illuccix should receive marketing authorization.This decision sets the stage for the administrative national phase, where authorizations will be finalized to facilitate the commercial launch of Illuccix across the region.Once launched, Illuccix will enable the detection of prostate-specific membrane antigen-positive lesions with PET imaging in adults with prostate cancer, according to the company.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","BK7067","TLX.AU","TLX"],"gpt_icon":0},{"id":"2504282509","title":"ASX Alert-Illuccix Receives European Approval-Tlx.ax","url":"https://stock-news.laohu8.com/highlight/detail?id=2504282509","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504282509?lang=en_us&edition=fundamental","pubTime":"2025-01-17 05:23","pubTimestamp":1737062609,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250116:nFWN3OC11U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","TLX.AU"],"gpt_icon":0},{"id":"2503663434","title":"How buying undervalued ASX stocks can deliver great returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2503663434","media":"Small Caps","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503663434?lang=en_us&edition=fundamental","pubTime":"2025-01-15 08:31","pubTimestamp":1736901091,"startTime":"0","endTime":"0","summary":"One of the enduring themes of US investment is a strategy known as buying the “dogs of the Dow”.The idea is that companies that have had a really bad year but still pay a dividend often surprise on the upside later on, either due to mean reversion, managerial change or a combination of both.Some good local examples from 2024 include the turnarounds of Downer EDI  which enjoyed a rise of more than 20% during 2024 and Insignia Financial  with a rise of more than 40%.Both of these companies went through a management shake-up and refocussed on their core businesses to achieve an overdue good result for investors.Unfortunately, there is no shortage of companies that meet the “dogs of the ASX’’ label and which have to some extent entered into a rebuild phase.Interestingly the need to adopt something like the “dogs of the ASX” strategy is also shown by the decidedly patchy performance of the ASX 200 during 2024.","market":"hk","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/01/undervalued-ASX-stocks-2025.jpg","type":0,"news_type":0,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/01/undervalued-ASX-stocks-2025.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://smallcaps.com.au/how-buying-undervalued-asx-stocks-can-deliver-great-returns/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"smallcap_stock","symbols":["ALL.AU","ANZ.AU","BK7510","WBC.AU","BK7012","BK7078","MIN.AU","BK7062","BK7153","IFL.AU","FBU.AU","NEC.AU","WES.AU","BK7145","DMP.AU","BK7507","ZIP.AU","360.AU","BK7046","BK7511","DOW.AU","BK7016","BK7041","TLX.AU","LIC.AU","BK7052","BK7094","BK7064","PME.AU","GMG.AU","BK7113","BK7506","SIG.AU","BK7137","BK7093","RHC.AU","BK7155","TAH.AU","IGO.AU","MQG.AU","BK7067","BK7095","BK7103","BK7504","CBA.AU","SGR.AU","BK7135","NAB.AU","BK7099"],"gpt_icon":0},{"id":"2503443686","title":"BUZZ-Morningstar hikes fair value estimate on Australia's Telix on revenue growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2503443686","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503443686?lang=en_us&edition=fundamental","pubTime":"2025-01-15 04:25","pubTimestamp":1736886305,"startTime":"0","endTime":"0","summary":"** Morningstar says it is upbeat on Australia's Telix Pharmaceuticals    after co reported FY24 revenue ahead of its own and brokerage's forecasts   ** \"Telix is broadly tracking our expectations and we leave our constant-currency forecasts broadly unchanged,\" says brokerage   ** Morningstar raises fair value estimate on stock by 6% to A$18, largely on stronger U.S. dollar   ** Seven of eight analysts rate the stock \"buy\" or higher, one \"hold\"; their median PT is A$23.80 – LSEG data   ** Stock has gained 1.5% YTD, as of last close ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","MORN"],"gpt_icon":0},{"id":"2503688189","title":"Your top-tipped ASX growth stocks for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503688189","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503688189?lang=en_us&edition=fundamental","pubTime":"2025-01-15 04:00","pubTimestamp":1736884823,"startTime":"0","endTime":"0","summary":"Few sectors have offered more extraordinary growth in the past few years than the tech sector. It’s not a sector that dominates the ASX, though perhaps we are witnessing that change before our very eyes.Australia has been the birthplace of some fantastic technology solutions – and home-grown Canva is expected to be an extremely popular IPO in the US in 2025. According to Austrade, the Aussie tech sector has also contributed $167 billion to the economy, growing 80% in five years. It’s overtaken banking and mining, despite being underrepresented in the ASX200.In the future, will companies like Wisetech or Life360 be as ubiquitous in portfolios asCommonwealth Bank or BHP are today?In this wire, you’ll find your 10 top-tipped growth stocks on the ASX and a deeper dive into some of the key metrics.Top tipped growth stocks. Source: Livewire 2025 Outlook Series Survey, 10/12/24-20/12/24. Australian resources have also returned to the fore, with BHP Group not only benefitting f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/your-top-tipped-asx-growth-stocks-for-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/your-top-tipped-asx-growth-stocks-for-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["BK7504","BK7095","BK7501","BK7503","XAO.AU","BK7507","CAT.AU","LIF","TLX.AU","BK7016","BK7508","BK7511","MIN.AU","WTC.AU","BK7067","BK7084","XJO.AU","BHP.AU","BK7094","PME.AU","CSL.AU","TNE.AU","XKO.AU","360.AU","BK4023"],"gpt_icon":0},{"id":"2503542599","title":"BUZZ-Australia's Telix Pharmaceuticals rises on FY24 revenue forecast beat","url":"https://stock-news.laohu8.com/highlight/detail?id=2503542599","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503542599?lang=en_us&edition=fundamental","pubTime":"2025-01-14 11:58","pubTimestamp":1736827085,"startTime":"0","endTime":"0","summary":"** Shares of Telix Pharmaceuticals    rise as much as 7.4% to A$25.79, their biggest gain since Sept. 20, 2024   ** Stock hits highest level since Dec. 18, 2024 ** The biopharmaceutical co records rev","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU","XAO.AU","XJO.AU","XKO.AU"],"gpt_icon":0},{"id":"2503569901","title":"Why CAR Group, Peninsula Energy, Star, and Telix shares are charging higher today","url":"https://stock-news.laohu8.com/highlight/detail?id=2503569901","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503569901?lang=en_us&edition=fundamental","pubTime":"2025-01-14 09:11","pubTimestamp":1736817079,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is back on form and pushing higher. At the time of writing, the benchmark index is up 0.3% to 8,215.2 points. Four ASX shares that are rising more than most today are l","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/14/why-car-group-peninsula-energy-star-and-telix-shares-are-charging-higher-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7002","CAR","XJO.AU","BK7078","BK7083","BK7503","TLX.AU","SGR.AU","PEN.AU","CAR.AU","BK7067"],"gpt_icon":0},{"id":"2503566090","title":"Australia's Telix eyes best day in nearly 4 months on revenue growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2503566090","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503566090?lang=en_us&edition=fundamental","pubTime":"2025-01-14 09:10","pubTimestamp":1736817012,"startTime":"0","endTime":"0","summary":"Australia's Telix eyes best day in nearly 4 months on revenue growthBy Rajasik MukherjeeJan 14 (Reuters) - Shares of Australia's Telix Pharmaceuticals TLX.AX jumped to a near four-week high on Tuesday","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nL4N3OA01H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX.AU"],"gpt_icon":0},{"id":"2503816568","title":"Guess which ASX 200 share is up 7% after smashing FY24 guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2503816568","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503816568?lang=en_us&edition=fundamental","pubTime":"2025-01-14 07:21","pubTimestamp":1736810476,"startTime":"0","endTime":"0","summary":"The Telix Pharmaceuticals Ltd  share price is roaring higher on Tuesday morning. At the time of writing, the ASX 200 share is up 7% to $25.79. Why is this ASX 200 share jumping?","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/14/guess-which-asx-200-share-is-up-7-after-smashing-fy24-guidance/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7095","IND.AU","TLX.AU","BK7067"],"gpt_icon":0},{"id":"2503745551","title":"ASX Preview: Australian Shares to Open Higher Despite Mixed Wall Street Session","url":"https://stock-news.laohu8.com/highlight/detail?id=2503745551","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503745551?lang=en_us&edition=fundamental","pubTime":"2025-01-14 06:33","pubTimestamp":1736807596,"startTime":"0","endTime":"0","summary":"Australian shares are headed for a higher open Tuesday despite a mixed session on Wall Street overnight.The ANZ-Roy Morgan Australian Consumer Confidence Index is expected at 9:30 am Sydney time, whil","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7062","XAO.AU","BK7067","BK7078","SGR.AU","TLX.AU","MAF.AU","XKO.AU","XJO.AU"],"gpt_icon":0},{"id":"2503255981","title":"ASX Market Open: Monday bloodbath to turn into Oz shares, $A uptick | Jan 14, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2503255981","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503255981?lang=en_us&edition=fundamental","pubTime":"2025-01-14 05:50","pubTimestamp":1736805000,"startTime":"0","endTime":"0","summary":"After a downturn to start Week 3, things look to be turning around in Australia with ASX 200 futures pointing to a 0.5% rise – a gain of around 40 points – today.Though it’s still under enormous pressure, the Aussie dollar ticked up slightly too.Yesterday’s plunge was always going to be followed by a buying run eventually; that’s already started happening in the U.S. where Wall Street saw the Dow Jones bounce back higher and the S&P 500 recover through late intraday trading.Only the Nasdaq composite, weighed down by Nvidia  and Apple , stayed stuck mostly negative: It closed 0.8% lower.China has been a little topsy-turvy too, with problems around its two-speed economy  leaving its markets hovering at somewhat of a middle ground. One hurdle Beijing is trying to navigate is China’s unprecedented $992 billion trade surplus which it piled up through 2024.Sun Silver  also landed an “exceptional” extensional intercept at Maverick Springs.That’s Market Open, I’m Isaac McIntyre, stick with us ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-open-monday-bloodbath-to-turn-into-oz-shares-a-uptick-jan-14-2024-2025-01-14/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["TLX.AU","GL1.AU","LEG.AU","BK7138","BK7078","BK7095","SS1.AU","BK7067","SGR.AU","BK7504"],"gpt_icon":0},{"id":"2503556623","title":"Telix Pharmaceuticals' Revenue Surges 46% in Q4; Full-Year Revenue Beats Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2503556623","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503556623?lang=en_us&edition=fundamental","pubTime":"2025-01-14 05:43","pubTimestamp":1736804582,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) reported unaudited revenue of roughly $142 million for the fourth quarter of 2024, an increase of 46% from the year-earlier period's $97 million, according to a Monday ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX","TLX.AU"],"gpt_icon":0},{"id":"2503532068","title":"Best ASX 200 shares vs. best suburbs for property investment in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2503532068","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503532068?lang=en_us&edition=fundamental","pubTime":"2025-01-14 03:30","pubTimestamp":1736796600,"startTime":"0","endTime":"0","summary":"Were you invested in ASX 200 shares vs. property last year?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/14/best-asx-200-shares-vs-best-suburbs-for-property-investment-in-2024/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7103","BK7016","BK7054","ZIP.AU","XJO.AU","BK7096","BK7084","PNI.AU","TLX.AU","BK7067","SIG.AU","BK7062","XKO.AU","CU6.AU","XAO.AU","360.AU","CDA.AU","TNE.AU","BK7503","HUB.AU","BK7093","PME.AU","BK7094"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-19","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739919600000,"name":null,"time":"","dateTimestamp":1739883600000,"actualEps":null},{"date":"2024-08-22","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724284800000,"name":null,"time":"","dateTimestamp":1724248800000,"actualEps":null},{"date":"2024-02-22","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1708556400000,"name":null,"time":"","dateTimestamp":1708520400000,"actualEps":null},{"date":"2023-10-18","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1697583600000,"name":null,"time":"","dateTimestamp":1697547600000,"actualEps":null},{"date":"2023-08-23","symbol":"TLX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1692748800000,"name":null,"time":"","dateTimestamp":1692712800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX.AU\",market:\"AU\",,,undefined,":[]}}